Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huanglian capsule is a traditional Chinese medicine (TCM) preparation formulated as an oral capsule containing the extract of *Coptis chinensis* (Rhizoma Coptidis / Huanglian). The primary active components of Huanglian are isoquinoline alkaloids, most notably berberine, which exhibit potent anti-inflammatory, antimicrobial, and cardioprotective properties. In TCM, Huanglian is traditionally used to clear heat, dry dampness, purge fire, and detoxify. Clinically, Huanglian capsule has been evaluated, often in combination with other TCM formulations like Gongshao capsule (or Xiongshao capsule), for the treatment of unstable angina pectoris and coronary heart disease, where it is thought to target inflammatory pathways and improve endothelial function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huanglian capsule.